In the last 12 months, insiders at Aligos Therapeutics, Inc. ($ALGS) filed 86 transactions with the SEC: 2 open-market purchases totaling $6,004,149 and 0 sales totaling $0. Net insider sentiment: net buying.
Aligos Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Nuechterlein Carole (Not found) — 7 transactions totaling $6,004,149
- BLATT LAWRENCE (Chief Executive Officer) — 12 transactions totaling $461,858
- Scopa James Paul (Not found) — 7 transactions totaling $138,557
- Calhoun Lesley Ann (Other) — 1 transaction totaling $0
- Achneck Hardean (Chief Medical Officer) — 1 transaction totaling $0
View all SEC Filings for Aligos Therapeutics, Inc. (ALGS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Aneja Nikhil | Principal Accounting Officer | A | Stock Option (Right to Buy) | 9450 | $0.00 | 9,450.0000 | 6,153,507 | 9999.99% | 0.15% |
| March 9, 2026 | Calhoun Lesley Ann | See Remarks | A | Stock Option (Right to Buy) | 37485 | $0.00 | 37,485.0000 | 6,153,507 | 9999.99% | 0.61% |
| March 9, 2026 | BLATT LAWRENCE | President and CEO | A | Stock Option (Right to Buy) | 105840 | $0.00 | 105,840.0000 | 6,153,507 | 9999.99% | 1.72% |
| March 9, 2026 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 23310 | $0.00 | 23,310.0000 | 6,153,507 | 9999.99% | 0.38% |
| July 16, 2025 | BLATT LAWRENCE | President and CEO | A | Stock Option (Right to Buy) | 179800 | $0.00 | 179,800.0000 | 3,864,436 | 9999.99% | 4.65% |
| July 16, 2025 | Calhoun Lesley Ann | See Remarks | A | Stock Option (Right to Buy) | 40185 | $0.00 | 40,185.0000 | 3,864,436 | 9999.99% | 1.04% |
| July 16, 2025 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 3,864,436 | 9999.99% | 0.41% |
| June 25, 2025 | Martell Bridget A | Not found | A | Stock Option (Right to Buy) | 5860 | $0.00 | 5,860.0000 | 3,864,436 | 9999.99% | 0.15% |
| June 25, 2025 | Chavez Margarita | Not found | A | Stock Option (Right to Buy) | 5860 | $0.00 | 5,860.0000 | 3,864,436 | 9999.99% | 0.15% |
| June 25, 2025 | Preston Heather | Not found | A | Stock Option (Right to Buy) | 5860 | $0.00 | 5,860.0000 | 3,864,436 | 9999.99% | 0.15% |
| June 25, 2025 | Hirth Peter | Not found | A | Stock Option (Right to Buy) | 5860 | $0.00 | 5,860.0000 | 3,864,436 | 9999.99% | 0.15% |
| June 25, 2025 | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 5860 | $0.00 | 5,860.0000 | 3,864,436 | 9999.99% | 0.15% |
| June 25, 2025 | Nuechterlein Carole | Not found | A | Stock Option (Right to Buy) | 5860 | $0.00 | 5,860.0000 | 3,864,436 | 9999.99% | 0.15% |
| Feb. 28, 2025 | BLATT LAWRENCE | President and CEO | A | Stock Option (Right to Buy) | 140103 | $0.00 | 140,103.0000 | 3,864,436 | 9999.99% | 3.63% |
| Feb. 28, 2025 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 21693 | $0.00 | 21,693.0000 | 3,864,436 | 9999.99% | 0.56% |
| Feb. 28, 2025 | Calhoun Lesley Ann | See Remarks | A | Stock Option (Right to Buy) | 47271 | $0.00 | 47,271.0000 | 3,864,436 | 9999.99% | 1.22% |
| Oct. 8, 2024 | Achneck Hardean | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 79,900,000 | 9999.99% | 0.09% |
| Sept. 4, 2024 | BLATT LAWRENCE | Chief Executive Officer | A | Stock Option (Right to Buy) | 33920 | $0.00 | 33,920.0000 | 79,900,000 | 9999.99% | 0.04% |
| Sept. 4, 2024 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 79,900,000 | 9999.99% | 0.01% |
| Sept. 4, 2024 | Calhoun Lesley Ann | Not found | A | Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 79,900,000 | 9999.99% | 0.01% |
| Aug. 7, 2024 | Preston Heather | Not found | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 3,003,855 | 9999.99% | 3.99% |
| Aug. 7, 2024 | Chavez Margarita | Not found | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 3,003,855 | 9999.99% | 3.99% |
| June 27, 2024 | Hirth Peter | Not found | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 3,003,855 | 9999.99% | 2.00% |
| June 27, 2024 | Martell Bridget A | Not found | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 3,003,855 | 9999.99% | 2.00% |
| June 27, 2024 | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 3,003,855 | 9999.99% | 2.00% |
| June 27, 2024 | Nuechterlein Carole | Not found | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 3,003,855 | 9999.99% | 2.00% |
| March 1, 2024 | BLATT LAWRENCE | Chief Executive Officer | A | Stock Option (Right to Buy) | 965435 | $0.00 | 965,435.0000 | 3,003,855 | 9999.99% | 32.14% |
| March 1, 2024 | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 72000 | $0.00 | 72,000.0000 | 3,003,855 | 9999.99% | 2.40% |
| March 1, 2024 | Calhoun Lesley Ann | Not found | A | Stock Option (Right to Buy) | 308940 | $0.00 | 308,940.0000 | 3,003,855 | 9999.99% | 10.29% |
| March 1, 2024 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 72000 | $0.00 | 72,000.0000 | 3,003,855 | 9999.99% | 2.40% |
| Feb. 27, 2024 | Nuechterlein Carole | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.50% |
| Feb. 28, 2024 | Nuechterlein Carole | Not found | A | Stock Option (Right to Buy) | 4411 | $0.00 | 4,411.0000 | 3,003,855 | 9999.99% | 0.15% |
| Feb. 27, 2024 | Martell Bridget A | Not found | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 1.00% |
| Feb. 28, 2024 | Martell Bridget A | Not found | A | Stock Option (Right to Buy) | 8823 | $0.00 | 8,823.0000 | 3,003,855 | 9999.99% | 0.29% |
| Feb. 28, 2024 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 18750 | $0.00 | 18,750.0000 | 3,003,855 | 9999.99% | 0.62% |
| Feb. 27, 2024 | Hirth Peter | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.50% |
| Feb. 28, 2024 | Hirth Peter | Not found | A | Stock Option (Right to Buy) | 4411 | $0.00 | 4,411.0000 | 3,003,855 | 9999.99% | 0.15% |
| Feb. 27, 2024 | Scopa James Paul | Not found | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 1.00% |
| Feb. 28, 2024 | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 8823 | $0.00 | 8,823.0000 | 3,003,855 | 9999.99% | 0.29% |
| Feb. 27, 2024 | McClure Matthew W. | Chief Medical Officer | D | Stock Option (Right to Buy) | 255626 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 8.51% |
| Feb. 27, 2024 | McClure Matthew W. | Chief Medical Officer | D | Stock Option (Right to Buy) | 92000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 3.06% |
| Feb. 27, 2024 | McClure Matthew W. | Chief Medical Officer | D | Stock Option (Right to Buy) | 23000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.77% |
| Feb. 28, 2024 | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 75183 | $0.00 | 75,183.0000 | 3,003,855 | 9999.99% | 2.50% |
| Feb. 28, 2024 | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 65713 | $0.00 | 65,713.0000 | 3,003,855 | 9999.99% | 2.19% |
| Feb. 28, 2024 | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 16428 | $0.00 | 16,428.0000 | 3,003,855 | 9999.99% | 0.55% |
| Feb. 27, 2024 | Calhoun Lesley Ann | Not found | D | Stock Option (Right to Buy) | 176237 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 5.87% |
| Feb. 27, 2024 | Calhoun Lesley Ann | Not found | D | Stock Option (Right to Buy) | 105000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 3.50% |
| Feb. 27, 2024 | Calhoun Lesley Ann | Not found | D | Stock Option (Right to Buy) | 26250 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.87% |
| Feb. 28, 2024 | Calhoun Lesley Ann | Not found | A | Stock Option (Right to Buy) | 51833 | $0.00 | 51,833.0000 | 3,003,855 | 9999.99% | 1.73% |
| Feb. 28, 2024 | Calhoun Lesley Ann | Not found | A | Stock Option (Right to Buy) | 74998 | $0.00 | 74,998.0000 | 3,003,855 | 9999.99% | 2.50% |
| Feb. 28, 2024 | Calhoun Lesley Ann | Not found | A | Stock Option (Right to Buy) | 18750 | $0.00 | 18,750.0000 | 3,003,855 | 9999.99% | 0.62% |
| Feb. 27, 2024 | BLATT LAWRENCE | Chief Executive Officer | D | Stock Option (Right to Buy) | 450000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 14.98% |
| Feb. 27, 2024 | BLATT LAWRENCE | Chief Executive Officer | D | Stock Option (Right to Buy) | 323400 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 10.77% |
| Feb. 27, 2024 | BLATT LAWRENCE | Chief Executive Officer | D | Stock Option (Right to Buy) | 80850 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 2.69% |
| Feb. 28, 2024 | BLATT LAWRENCE | Chief Executive Officer | A | Stock Option (Right to Buy) | 132352 | $0.00 | 132,352.0000 | 3,003,855 | 9999.99% | 4.41% |
| Feb. 28, 2024 | BLATT LAWRENCE | Chief Executive Officer | A | Stock Option (Right to Buy) | 230999 | $0.00 | 230,999.0000 | 3,003,855 | 9999.99% | 7.69% |
| Feb. 28, 2024 | BLATT LAWRENCE | Chief Executive Officer | A | Stock Option (Right to Buy) | 57749 | $0.00 | 57,749.0000 | 3,003,855 | 9999.99% | 1.92% |
| Feb. 27, 2024 | Symons Julian A. | See Remarks | D | Stock Option (Right to Buy) | 200000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 6.66% |
| Feb. 27, 2024 | Symons Julian A. | See Remarks | D | Stock Option (Right to Buy) | 105000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 3.50% |
| Feb. 27, 2024 | Symons Julian A. | See Remarks | D | Stock Option (Right to Buy) | 26250 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.87% |
| Feb. 28, 2024 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 58822 | $0.00 | 58,822.0000 | 3,003,855 | 9999.99% | 1.96% |
| Feb. 28, 2024 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 74998 | $0.00 | 74,998.0000 | 3,003,855 | 9999.99% | 2.50% |
| Feb. 27, 2024 | Nielsen Jack | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.50% |
| Feb. 28, 2024 | Nielsen Jack | Not found | A | Stock Option (Right to Buy) | 4411 | $0.00 | 4,411.0000 | 3,003,855 | 9999.99% | 0.15% |
| Oct. 25, 2023 | Scopa James Paul | Not found | A | Common Stock | 183083 | $0.76 | 183,083.0000 | 0 | 9999.99% | 0.00% |
| Oct. 25, 2023 | Scopa James Paul | Not found | A | Warrant (Right to Buy) | 91541 | $0.13 | 91,541.0000 | 0 | 9999.99% | 0.00% |
| Oct. 25, 2023 | BLATT LAWRENCE | Chief Executive Officer | A | Warrants (Right to Buy) | 305138 | $0.13 | 305,138.0000 | 0 | 9999.99% | 0.00% |
| Oct. 25, 2023 | BLATT LAWRENCE | Chief Executive Officer | A | Common Stock | 610277 | $0.76 | 2,120,633.0000 | 0 | 40.41% | 0.00% |
| Oct. 25, 2023 | Nuechterlein Carole | Not found | P | Warrant (Right to Buy) | 3966800 | $0.13 | 3,966,800.0000 | 0 | 9999.99% | 0.00% |
| Oct. 25, 2023 | Nuechterlein Carole | Not found | P | Common Stock | 7933601 | $0.76 | 11,025,941.0000 | 0 | 256.56% | 0.00% |
| Sept. 8, 2023 | BLATT LAWRENCE | Chief Executive Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | Calhoun Lesley Ann | Not found | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | Quan Lucinda Y. | See Remarks | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| July 20, 2023 | Nuechterlein Carole | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 20, 2023 | Martell Bridget A | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 20, 2023 | Nielsen Jack | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 20, 2023 | Hirth Peter | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| July 20, 2023 | Scopa James Paul | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | Beigelman Leonid | President | A | Stock Option (Right to Buy) | 169500 | $0.00 | 169,500.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | BLATT LAWRENCE | Chief Executive Officer | A | Stock Option (Right to Buy) | 242500 | $0.00 | 242,500.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | Symons Julian A. | See Remarks | A | Stock Option (Right to Buy) | 78750 | $0.00 | 78,750.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | Calhoun Lesley Ann | Other | A | Stock Option (Right to Buy) | 78750 | $0.00 | 78,750.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | Quan Lucinda Y. | See Remarks | A | Stock Option (Right to Buy) | 78750 | $0.00 | 78,750.0000 | 0 | 9999.99% | 0.00% |